Immunocore Holdings Ltd (IMCR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $32.04
• Market Cap: $1.63B
• EPS: $-0.58
• 52-Week High: $40.71
• 52-Week Low: $23.15

Market Sentiment

Immunocore Holdings Ltd currently has a Bullish sentiment score of 0.36.

About Immunocore Holdings Ltd

Immunocore Holdings Limited is a pioneering biotechnology company headquartered in Abingdon, UK, dedicated to the development of cutting-edge immunotherapies for cancer, infectious diseases, and autoimmune disorders. Utilizing its proprietary T cell receptor technology, Immunocore aims to harness and amplify the body’s immune response, driving forward transformative treatment options with the potential to significantly enhance patient outcomes. The company boasts a solid pipeline of clinical ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immunocore Holdings Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMCR pay dividends?

Immunocore Holdings Ltd (IMCR) does not currently pay a regular dividend.

What is IMCR's market cap?

Immunocore Holdings Ltd (IMCR) has a market capitalization of $1.63B with a current stock price of $32.04.